相似文献
1
Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.
Thorax. 2004 Feb;59(2):164-9. doi: 10.1136/thorax.2003.006494.
2
Genetic epidemiology of alpha-1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America.
Clin Genet. 2003 Nov;64(5):382-97. doi: 10.1034/j.1399-0004.2003.00143.x.
3
Estimated numbers and prevalence of PI*S and PI*Z deficiency alleles of alpha1-antitrypsin deficiency in Asia.
Eur Respir J. 2006 Dec;28(6):1091-9. doi: 10.1183/09031936.00029806. Epub 2006 Sep 27.
4
Challenging identification of a novel PiISF and the rare PiMmaltonZ α1-antitrypsin deficiency variants in two patients.
Am J Clin Pathol. 2014 May;141(5):742-6. doi: 10.1309/AJCPR7EIQS8PIMLV.
5
Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency.
J Med Genet. 2005 Mar;42(3):282-7. doi: 10.1136/jmg.2004.023903.
6
Alpha1-antitrypsin review.
Clin Chest Med. 2014 Mar;35(1):39-50. doi: 10.1016/j.ccm.2013.10.001. Epub 2013 Dec 12.
7
Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk.
Thorax. 2004 Mar;59(3):259-64. doi: 10.1136/thx.2003.006502.
8
Alpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosed.
Environ Health Perspect. 2003 Dec;111(16):1851-4. doi: 10.1289/ehp.6511.
9
Alpha-1 antitrypsin Pi*Z gene frequency and Pi*ZZ genotype numbers worldwide: an update.
Int J Chron Obstruct Pulmon Dis. 2017 Feb 13;12:561-569. doi: 10.2147/COPD.S125389. eCollection 2017.
10
Estimated Worldwide Prevalence of the PI*ZZ Alpha-1 Antitrypsin Genotype in Subjects With Chronic Obstructive Pulmonary Disease.
Arch Bronconeumol. 2023 Jul;59(7):427-434. doi: 10.1016/j.arbres.2023.03.016. Epub 2023 Mar 30.
引用本文的文献
1
Susceptibility of alpha-1 antitrypsin deficiency variants to polymer-blocking therapy.
JCI Insight. 2025 Jul 8;10(15). doi: 10.1172/jci.insight.194354. eCollection 2025 Aug 8.
2
Characterization of the Mmalton carrier's cohort within the EARCO (European Alpha- 1 Antitrypsin Research Collaboration) registry.
BMC Pulm Med. 2025 Apr 23;25(1):187. doi: 10.1186/s12890-025-03651-8.
3
Comparison of COVID-19 Outcomes With Alpha-1 Antitrypsin Deficiency Prevalence in Europe: A Cross-Sectional Study.
Cureus. 2023 Jan 27;15(1):e34293. doi: 10.7759/cureus.34293. eCollection 2023 Jan.
4
Association of Alpha-1 Antitrypsin Pi*Z Allele Frequency and Progressive Liver Fibrosis in Two Chronic Hepatitis C Cohorts.
J Clin Med. 2022 Dec 29;12(1):253. doi: 10.3390/jcm12010253.
5
Radiographic Phenotypes Affect the Risk of Inhaled Corticosteroid-Associated Pneumonia in Patients with COPD.
Int J Chron Obstruct Pulmon Dis. 2022 Sep 18;17:2301-2315. doi: 10.2147/COPD.S372735. eCollection 2022.
6
Global 5'-UTR RNA structure regulates translation of a SERPINA1 mRNA.
Nucleic Acids Res. 2022 Sep 23;50(17):9689-9704. doi: 10.1093/nar/gkac739.
7
The emerging role of proteases in α-antitrypsin deficiency and beyond.
ERJ Open Res. 2021 Nov 22;7(4). doi: 10.1183/23120541.00494-2021. eCollection 2021 Oct.
8
A Novel Detection Method to Identify Individuals with Alpha-1 Antitrypsin Deficiency: Linking Prescription of COPD Medications with the Patient-Facing Electronic Medical Record.
Chronic Obstr Pulm Dis. 2022 Jan 27;9(1):26-33. doi: 10.15326/jcopdf.2021.0260.
9
Correlation between α1-Antitrypsin Deficiency and SARS-CoV-2 Infection: Epidemiological Data and Pathogenetic Hypotheses.
J Clin Med. 2021 Sep 29;10(19):4493. doi: 10.3390/jcm10194493.
10
Variants of and the increasing complexity of testing for alpha-1 antitrypsin deficiency.
Ther Adv Chronic Dis. 2021 Jul 29;12_suppl:20406223211015954. doi: 10.1177/20406223211015954. eCollection 2021.
本文引用的文献
1
Genetic epidemiology of alpha-1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain.
Clin Genet. 2003 Jun;63(6):490-509. doi: 10.1034/j.1399-0004.2003.00078.x.
2
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.
Chest. 2002 Nov;122(5):1818-29. doi: 10.1378/chest.122.5.1818.
3
Alpha1-antitrypsin deficiency: a report from the 2nd meeting of the Alpha One International Registry, Rapallo (Genoa, Italy), 2001.
Eur Respir J. 2002 Oct;20(4):1050-6. doi: 10.1183/09031936.02.00302502.
4
Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
Ann Intern Med. 2002 Feb 19;136(4):270-9. doi: 10.7326/0003-4819-136-4-200202190-00006.
5
A fast amplification-reverse hybridization assay kit to detect the most frequent deficient variants in the alpha-1-antitrypsin gene.
Respiration. 2002;69(1):81-5. doi: 10.1159/000049375.
6
Alpha1-antitrypsin deficiency--a model for conformational diseases.
N Engl J Med. 2002 Jan 3;346(1):45-53. doi: 10.1056/NEJMra010772.
7
Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction.
Am J Respir Crit Care Med. 2001 Oct 15;164(8 Pt 1):1419-24. doi: 10.1164/ajrccm.164.8.2105002.
8
Alpha-1-antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys.
Clin Genet. 2001 Jul;60(1):31-41. doi: 10.1034/j.1399-0004.2001.600105.x.
9
Patterns of haplotype diversity within the serpin gene cluster at 14q32.1: insights into the natural history of the alpha1-antitrypsin polymorphism.
Hum Genet. 2001 Jan;108(1):20-30. doi: 10.1007/s004390000434.
10
Usefulness of a national registry of alpha-1-antitrypsin deficiency. The Spanish experience.
Respir Med. 1998 Oct;92(10):1181-7. doi: 10.1016/s0954-6111(98)90418-8.
Zotero 插件